Compare HRMY & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | NSP |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 834.9M |
| IPO Year | 2020 | 1996 |
| Metric | HRMY | NSP |
|---|---|---|
| Price | $27.73 | $20.55 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $46.70 | ★ $47.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 12.06% |
| EPS Growth | ★ 7.97 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | $868,453,000.00 | ★ $6,812,000,000.00 |
| Revenue This Year | $19.87 | $4.27 |
| Revenue Next Year | $12.49 | $5.43 |
| P/E Ratio | $10.62 | ★ N/A |
| Revenue Growth | ★ 21.51 | 3.51 |
| 52 Week Low | $25.52 | $18.57 |
| 52 Week High | $40.87 | $91.12 |
| Indicator | HRMY | NSP |
|---|---|---|
| Relative Strength Index (RSI) | 30.66 | 27.06 |
| Support Level | $27.66 | N/A |
| Resistance Level | $38.91 | $48.32 |
| Average True Range (ATR) | 1.25 | 1.36 |
| MACD | 0.08 | 0.40 |
| Stochastic Oscillator | 54.02 | 39.83 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.